Cite
Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica
MLA
Conter, V., et al. Intensive BFM Chemotherapy for Childhood ALL: Interim Analysis of the AIEOP-ALL 91 Study. Associazione Italiana Ematologia Oncologia Pediatrica. 1998. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1346404826&authtype=sso&custid=ns315887.
APA
Conter, V., Aricò, M., Valsecchi, M., Rizzari, C., Testi, A., Miniero, R., Di Tullio, M., Lo Nigro, L., Pession, A., Rondelli, R., Messina, C., Santoro, N., Mori, P., De Rossi, G., Tamaro, P., Silvestri, D., Biondi, A., Basso, G., Masera, G., … Masera, G. (1998). Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
Chicago
Conter, V, M Aricò, M Valsecchi, C Rizzari, A Testi, R Miniero, M Di Tullio, et al. 1998. “Intensive BFM Chemotherapy for Childhood ALL: Interim Analysis of the AIEOP-ALL 91 Study. Associazione Italiana Ematologia Oncologia Pediatrica.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1346404826&authtype=sso&custid=ns315887.